Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction, Health Technology Assessment, May 2011, National Institute for Health Research,
DOI: 10.3310/hta15suppl1/04.
You can read the full text:
Contributors
The following have contributed to this page
